Separated analysis of primary and metastatic samples revealed significantly lower expression of PTCH1 and SUFU in advanced melanoma, confirming the relevance of the Hh signaling pathway in melanoma progression (Figure 2). The gene discussed is SUFU; the disease is melanoma.